July 25, 2014
Ono Pharmaceutical and Bristol-Myers Squibb (BMS) of the US announced on July 24 that they have signed a strategic collaboration agreement to jointly develop and commercialize in Japan, South Korea, and Taiwan five immuno-oncology products that attack cancer by leveraging...read more